United States · FDA National Drug Code directory

LAROTRECTINIB

Source ingredient · 7 source records

Names are grouped within this source and country. A shared ingredient does not establish interchangeable medicines.

United States · Source reference 50419-390_0e3ba6e7-af8d-4840-9409-a537a09e1263

VITRAKVI

CAPSULE / Bayer HealthCare Pharmaceuticals Inc.

United States · Source reference 50419-391_0e3ba6e7-af8d-4840-9409-a537a09e1263

VITRAKVI

CAPSULE / Bayer HealthCare Pharmaceuticals Inc.

United States · Source reference 50419-392_0e3ba6e7-af8d-4840-9409-a537a09e1263

VITRAKVI

SOLUTION, CONCENTRATE / Bayer HealthCare Pharmaceuticals Inc.

United States · Source reference 50419-393_0e3ba6e7-af8d-4840-9409-a537a09e1263

VITRAKVI

SOLUTION, CONCENTRATE / Bayer HealthCare Pharmaceuticals Inc.

United States · Source reference 71777-390_5b9e7961-f843-49d8-94b5-a2ce2c9efa46

VITRAKVI

CAPSULE / Loxo Oncology, Inc.

United States · Source reference 71777-391_5b9e7961-f843-49d8-94b5-a2ce2c9efa46

VITRAKVI

CAPSULE / Loxo Oncology, Inc.

United States · Source reference 71777-392_5b9e7961-f843-49d8-94b5-a2ce2c9efa46

VITRAKVI

SOLUTION / Loxo Oncology, Inc.

Browse ingredients in United States →
LAROTRECTINIB | Molindra Medicines